GeneDx Corp.

NASDAQ: WGS · Real-Time Price · USD
126.31
3.43 (2.79%)
At close: Aug 15, 2025, 3:59 PM
125.50
-0.64%
After-hours: Aug 15, 2025, 06:01 PM EDT

GeneDx Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-52.29M -175.77M -548.98M -245.39M
Depreciation & Amortization
21.95M 35.83M 59.31M 21.81M
Stock-Based Compensation
9.14M -326K 41.98M 219.42M
Other Working Capital
3.72M -2.53M -8.46M 123K
Other Non-Cash Items
17.79M -721K 141.53M 1.62M
Deferred Income Tax
-343K -926K -49.12M -195.97M
Change in Working Capital
-24.75M -38.24M 36.13M 8.08M
Operating Cash Flow
-28.5M -180.15M -319.15M -190.43M
Capital Expenditures
-5.49M -5.71M -14.32M -20.79M
Cash Acquisitions
n/a -8.11M -127M n/a
Purchase of Investments
-66.3M -47.67M n/a n/a
Sales Maturities Of Investments
41.66M 17.77M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-30.13M -43.73M -141.33M -20.79M
Debt Repayment
-3.23M 42.95M -3.29M -13.47M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
891K 285K 2.95M 65.05M
Financial Cash Flow
44.16M 186.24M 197.31M 493.73M
Net Cash Flow
-14.47M -37.72M -263.17M 282.51M
Free Cash Flow
-33.99M -185.86M -333.48M -211.22M